Pharmaceutical Intervention: description of the role of the clinical pharmacist in intensive care units
Objective: To describe and analyze the profile of pharmaceutical interventions by identifying and classifying drug-related problems (DRP) and carrying out pharmaceutical interventions in order to highlight the importance of the intensivist clinical pharmacist. Methodology: Cross-sectional, descriptive and retrospective study of the results of the pharmacotherapeutic monitoring service aimed at critically ill patients admitted to the Cardiological and General ICUs of a state public hospital. Data were collected from September 1, 2020 to March 30, 2021, through an institutional pharmacotherapeutic follow-up report and the DRPs identified, quantified and classified according to the Pharmaceutical Care Network Europe. The drugs involved in the problems were categorized using the Anatomical Therapeutic Chemical. Results: A total of 331 patients were followed up during the study period, with the identification of 181 MRPs. Of these, most were related to adverse event (possibly) representing (34.8%) and unavailability or inadequacy of pharmaceutical presentation (29.8%). The main causes of DRP identified were inadequate pharmaceutical form (19.3%) and unavailable prescribed medication (19.3%). Most of the problems (24%) were related to the class of drugs that act on the nervous system and the class of general anti-infectives for systemic use (23%). Of the recommendations made for the optimization of pharmacotherapy, 98.3% were accepted, with the suggestion of changing the pharmaceutical form prevailing (22.1%). Conclusion: The high acceptability of the interventions suggested by the intensivist clinical pharmacist reinforces the importance and need for the clinical services provided by this health professional.
How to Cite
Copyright (c) 2022 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.